News 05. März 2024 Immunocore turns to Oncobit platform The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the U...
Aktuell 05. März 2024 Immunocore setzt auf Plattform von Oncobit Die britische Biotech-Firma Immunocore nutzt in Zukunft die Plattform des Medtech-Unternehmens Oncobit, einer Ausgliederung der Universität Züric...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 09. Apr. 2024 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
News 11. Apr. 2024 Circunis obtains funding from the Seedling Foundation Circunis has secured financing to establish an online marketplace that can be used to trade surplus food and by-products. Following in the footst...
News 03. Nov. 2023 Schindler wins award for MetaCore platform MetaCore, the new platform developed by Schindler for the repurposing of buildings, has won the Award of Excellence 2023 from the Council on Tall...
Aktuell 03. Nov. 2023 Schindler erhält Preis für Plattform MetaCore Schindlers Plattform für die Umnutzung von Gebäuden namens MetaCore wird vom Council on Tall Buildings and Urban Habitat mit dem Award of Excelle...
News 10. Mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 29. Nov. 2023 Meditron, EPFL’s new Large Language Model for medical knowledge EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.
News 07. Mai 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News 26. März 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Aktuell 22. Jan. 2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 18. Okt. 2023 Deloitte and Nexxiot enter into strategic partnership for logistics Deloitte is the new integration partner for Nexxiot technology. The consulting firm combines its regulatory competencies with Nexxiot’s network c...
Actualités 29. Nov. 2023 Meditron, le grand modèle de langage de l’EPFL pour le savoir médical Des scientifiques de l’EPFL ont dévoilé Meditron, un grand modèle de langage (LLM) innovant et open-source, spécialement conçu pour le domaine mé...
News 05. März 2024 Volaris Group agrees takeover of Zeit AG The Volaris Group, a software firm based in Canada, has announced that it has agreed a deal to acquire Zeit AG. Upon completion of the deal, the ...